SCHEMBL2272065

SCHEMBL2272065

Cc1cccc(C(=O)Nc2cc(-c3ccc(OC(=O)OC(C)(C)C)cc3)ccc2C(=O)OC(C)(C)C)c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.39
ELANE P08246 3/20 0.38
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
LMNA P02545 2/20 0.37
HTT P42858 2/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PRTN3 P24158 2/20 0.37
HPGD P15428 1/20 0.35
PYGL P06737 2/20 0.35
KDM4E B2RXH2 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
GAA P10253 2/20 0.34
MAOB P27338 1/20 0.34
POLB P06746 1/20 0.34
CRHBP P24387 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12395483 0.92 ACLY (0.42) ALDH1A1KMT2AMEN1ELANENPC1
SCHEMBL2269657 0.84 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL2272608 0.80 ALDH1A1 (0.47) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL2271189 0.80 ELANE (0.45) ALDH1A1KMT2AELANENPC1RAB9A
SCHEMBL2273301 0.78 MAPT (0.40) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL12117713 0.77 ALDH1A1 (0.50) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL12117652 0.77 HDAC1 (0.48) ALDH1A1KMT2AMEN1TP53HPGD
SCHEMBL2276160 0.77 MAOB (0.49) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL12117929 0.77 MAPT (0.43) ALDH1A1KMT2AMEN1LMNAHPGD
SCHEMBL12117763 0.76 HDAC1 (0.47) ALDH1A1KMT2AMEN1HPGDPYGL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 ALDH1A1 645/4885KMT2A 1669/4885MEN1 3105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.